APA (7th ed.) Citation

JE, F., TC, T., SW, M., L, B., C, N., K, H., & TH, K. (2022). Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19. Journal of thrombosis and thrombolysis, 53(2), 446. https://doi.org/10.1007/s11239-021-02552-x

Chicago Style (17th ed.) Citation

JE, Farrar, Trujillo TC, Mueller SW, Beltran L, Nguyen C, Hassell K, and Kiser TH. "Evaluation of a Patient Specific, Targeted-intensity Pharmacologic Thromboprophylaxis Protocol in Hospitalized Patients with COVID-19." Journal of Thrombosis and Thrombolysis 53, no. 2 (2022): 446. https://doi.org/10.1007/s11239-021-02552-x.

MLA (9th ed.) Citation

JE, Farrar, et al. "Evaluation of a Patient Specific, Targeted-intensity Pharmacologic Thromboprophylaxis Protocol in Hospitalized Patients with COVID-19." Journal of Thrombosis and Thrombolysis, vol. 53, no. 2, 2022, p. 446, https://doi.org/10.1007/s11239-021-02552-x.